This is a good time to look at biotech since it tends to hold up relatively well during bear markets and recessions, says Andrew Wang. He and David Nierengarten discuss the biotech sector. They talk about how Wedbush has outperform ratings for ARGX, GTHX, MRSN, TSVT, and SRRK. They also go over why the biotech sector could be a defensive play. Next, they mention investing strategies for biotech stocks. Tune in to find out more about the stock market today.
13 Jan 2023
Morning Trade Live
20 Dec 2022
Morning Trade Live
18 Jan 2023
Market On Close
14 Dec 2022
Morning Trade Live
14 Nov 2022
The Watch List
09 Dec 2022
The Watch List
22 Jan 2023